Crossmark

Salvage hypofractionated accelerated versus standard radiotherapy for the treatment of biochemical recurrence after radical prostatectomy (SHARE): the protocol of a prospective, randomized, open-label, superiority, multi-institutional trial

Crossref DOI link: https://doi.org/10.1186/s13063-021-05708-5

Published Online: 2021-10-21

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Park, Geumju

Kim, Yeon Joo

Ahn, Hanjong

Park, Won

Lee, Ji sung

Kim, Young Seok https://orcid.org/0000-0003-4739-4476
Funding

Funding for this research was provided by:

Asan Institute for Life Sciences, Asan Medical Center (2019-0154)
License Information

Text and Data Mining valid from 2021-10-21

Version of Record valid from 2021-10-21
More Information

Article History

Received: 1 April 2021

Accepted: 8 October 2021

First Online: 21 October 2021

Declarations

:

: Approval to conduct this study (version 1.6 on 4 February 2021) was granted by the Institutional Review Board of the Seoul Asan Medical Center (S2019-0333). It is mandatory to obtain informed consent from patients only by the principal investigator in each hospital prior to recruitment.

: Not applicable

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below